Research progress of fecal microbiota transplantation.
- Author:
Ting DAI
1
;
Tongyu TANG
Author Information
1. Department of Gastrointestinal, The First Hospital of Jilin University, Changchun 130021, China. tangtongyu@163.com.
- Publication Type:Journal Article
- MeSH:
Feces;
Humans;
Inflammatory Bowel Diseases;
Intestines;
Microbiota
- From:
Chinese Journal of Gastrointestinal Surgery
2015;18(7):733-737
- CountryChina
- Language:Chinese
-
Abstract:
Intestinal microbial ecosystem is the most complex and the largest micro-ecosystem of the mammals. The use of antibiotics can lead to a lot of major changes of the flora, making the intestinal flora damaged and impacted, even developing Clostridium difficile infection. Fecal microbiota transplantation (FMT) as a special organ transplant therapy, which can rebuild the intestinal flora, has raised the clinical concerns. It has been used in the refractory Clostridium difficile, inflammatory bowel disease, irritable bowel syndrome, chronic fatigue syndrome, and some non-intestinal diseases related to the metabolic disorders. But this method of treatment has not become a normal treatment, and many clinicians and patients can not accept it. This paper reviews relevant literature in terms of origin, indications, mechanism, production process, current situation and future research, and provide a reference for the clinical application of the treatment of fecal microbiota transplantation.
